Anaesthetic mechanisms: Update on the challenge of unravelling the mystery of anaesthesia

European Journal of Anaesthesiology

Volumn 26, Issue 10, 2009, Pages 807-820

  Lugli, Andrea Kopp ^a   Yost, Charles Spencer ^b   Kindler, Christoph H ^c,d  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Anaesthesia and Perioperative Medicine ^*  (Switzerland)

^d CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

Anaesthetic mechanisms; Anaesthetic targets; Anaesthetics; Ion channels; Receptors

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ADENOSINE RECEPTOR; ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; CYCLOPROPANE; DEXMEDETOMIDINE; ETHER; ETHER DERIVATIVE; ETOMIDATE; GLYCINE RECEPTOR; HALOGENATED HYDROCARBON; HALOTHANE; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT; ION CHANNEL; ISOFLURANE; KETAMINE; LUCIFERASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINIC RECEPTOR; NITRIC OXIDE; NITROUS OXIDE; ONDANSETRON; POTASSIUM CHANNEL; PROPOFOL; PROTEIN KINASE C; SEROTONIN RECEPTOR; XENON;

AGE DISTRIBUTION; AMNESIA; ANALGESIA; ANESTHESIOLOGICAL TECHNIQUES; BISPECTRAL INDEX; BRAIN METABOLISM; COGNITIVE DEFECT; CONSCIOUSNESS; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; ELECTROPHYSIOLOGY; GENERAL ANESTHESIA; GLUCOSE METABOLISM; HEART PROTECTION; HUMAN; IMMOBILIZATION; INHALATION ANESTHESIA; LIPID BILAYER; LIPID SOLUBILITY; MOLECULAR SIZE; MUSCLE RELAXATION; NAUSEA AND VOMITING; NERVE DEGENERATION; NEUROPHYSIOLOGY; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRESYNAPTIC NERVE; PROTEIN TARGETING; REVIEW; RIGHTING REFLEX; STEREOCHEMISTRY; STEREOSPECIFICITY;

ANESTHESIA, GENERAL; ANESTHETICS, GENERAL; ANIMALS; CENTRAL NERVOUS SYSTEM; DRUG DELIVERY SYSTEMS; ELECTROPHYSIOLOGY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; SOLUBILITY;

EID: 77951040843     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32832d6b0f     Document Type: Review

References (165)

1. Brandt L. Illustrated history of anaesthesia. Stuttgart, Germany: Wissenschaftliche Verlagsgesellschaft mbH; 1997.
2. Eger EI. What is general anesthetic action? Anesth Analg 1993;77: 408-409.
3. Antognini JF, Carstens E. In vivo characterization of clinical anaesthesia and its components. Br J Anaesth 2002;89:156-166.
4. Eger EI, Sonner JM. Anaesthesia defined (gentlemen, this is no humbug). Best Pract Res Clin Anaesthesiol 2006;20:23-29.
5. Urban BW, Bleckwenn M. Concepts and correlations relevant to general anaesthesia. Br J Anaesth 2002;89:3-16.
6. Eger EI, Saidman LJ, Brandstater B. Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiology 1965; 26:756-763.
7. De Jong RH, Eger EI. MAC expanded: AD50 and AD95 values of common inhalation anesthetics in man. Anesthesiology 1975; 42:384-389.
8. Antognini JF, Schwartz K. Exaggerated anesthetic requirements in the preferentially anesthetized brain. Anesthesiology 1993;79:1244-1249.
9. Rampil IJ, Mason P, Singh H. Anesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiology 1993;78:707-712.
10. King BS, Rampil IJ. Anesthetic depression of spinal motor neurons may contribute to lack of movement in response to noxious stimuli. Anesthesiology 1994;81:1484-1492.
11. Rampil IJ. Anesthetic potency is not altered after hypothermic spinal cord transection in rats. Anesthesiology 1994;80:606-610.
12. Eger EI, Raines DE, Shafer SL, et al. Is a new paradigm needed to explain how inhaled anesthetics produce immobility? Anesth Analg 2008;107:832-848.
13. Eger EI, Tang M, Liao M, et al. Inhaled anesthetics do not combine to produce synergistic effects regarding minimum alveolar anesthetic concentration in rats. Anesth Analg 2008;107:479-485.
14. Kandel ER. The molecular biology of memory storage: a dialogue between genes and synapses. Science 2001;294:1030-1038.
15. Alkire MT, Gruver R, Miller J, et al. Neuroimaging analysis of an anesthetic gas that blocks human emotional memory. Proc Natl Acad Sci U S A 2008;105:1722-1727.
16. Bennett HL, Davis HS, Giannini JA. Nonverbal response to intraoperative conversation. Br J Anaesth 1985; 57:174-179.
17. Block RI, Ghoneim MM, Sum Ping ST, Ali MA. Human learning during general anaesthesia and surgery. Br J Anaesth 1991;66:170-178.
18. Ghoneim MM, Block RI. Learning and consciousness during general anesthesia. Anesthesiology 1992;76:279-305.
19. Iselin-Chaves IA, Willems SJ, Jermann FC, et al. Investigation of implicit memory during isoflurane anesthesia for elective surgery using the process dissociation procedure. Anesthesiology 2005;103:925-933.
20. Angel A, LeBeau F. A comparison of the effects of propofol with other anaesthetic agents on the centripetal transmission of sensory information. Gen Pharmacol 1992;23:945-963.
21. Berg-Johnsen J, Langmoen IA. Isoflurane hyperpolarizes neurones in rat and human cerebral cortex. Acta Physiol Scand 1987; 130:679-685.
22. Moruzzi G, Magoun HW. Brain stem reticular formation and activation of the EEG. J Neuropsychiatry Clin Neurosci 1995;7:251-267.
23. Shimoji K, Fujioka H, Fukazawa T, et al. Anesthetics and excitatory/ inhibitory responses of midbrain reticular neurons. Anesthesiology 1984; 61:151-155.
24. Steriade M. Arousal: revisiting the reticular activating system. Science 1996;272:225-226.
25. Crick F, Koch C. A framework for consciousness. Nat Neurosci 2003;6:119-126.
26. Tononi G, Koch C. The neural correlates of consciousness: an update. Ann N Y Acad Sci 2008;1124:239-261.
27. Crick FC, Koch C. What is the function of the claustrum? Phil Trans R Soc B 2005;360:1271-1279.
28. Koch C, Greenfield S. How does consciousness happen? Sci Am 2007;297:76-83.
29. Hentschke H, Schwarz C, Antkowiak B. Neocortex is the major target of sedative concentrations of volatile anaesthetics: strong depression of firing rates and increase of GABAA receptor-mediated inhibition. Eur J Neurosci 2005;21:93-102.
30. Nelson LE, Guo TZ, Lu J, et al. The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway. Nat Neurosci 2002;5:979-984.
31. Avidan MS, Zhang L, Burnside BA, et al. Anesthesia awareness and the bispectral index. N Engl J Med 2008;358:1097-1108.
32. Hans P, Giwer J, Brichant JF, et al. Effect of an intubation dose of rocuronium on spectral entropy and Bispectral Index responses to laryngoscopy during propofol anaesthesia. Br J Anaesth 2006; 97:842- 847.
33. Dahaba AA. Different conditions that could result in the bispectral index indicating an incorrect hypnotic state. Anesth Analg 2005; 101:765- 773.
34. Schwab HS, Seeberger MD, Eger EI, et al. Sevoflurane decreases bispectral index values more than does halothane at equalMAC multiples. Anesth Analg 2004; 99:1723-1727.
35. Orser BA. Depth-of-anesthesia monitor and the frequency of intraoperative awareness. N Engl J Med 2008; 358:1189-1191.
36. Arhem P, Klement G, Nilsson J. Mechanisms of anesthesia: towards integrating network, cellular, and molecular level modeling. Neuropsychopharmacology 2003; 28 (Suppl 1):S40-S47.
37. Alkire MT, Haier RJ, Shah NK, Anderson CT. Positron emission tomography study of regional cerebral metabolism in humans during isoflurane anesthesia. Anesthesiology 1997; 86:549-557.
38. Alkire MT, Pomfrett CJ, Haier RJ, et al. Functional brain imaging during anesthesia in humans: effects of halothane on global and regional cerebral glucose metabolism. Anesthesiology 1999; 90:701-709.
39. Alkire MT, Haier RJ, Barker SJ, et al. Cerebral metabolism during propofol anesthesia in humans studied with positron emission tomography. Anesthesiology 1995; 82:393-403.
40. Fiset P, Paus T, Daloze T, et al. Brain mechanisms of propofol-induced loss of consciousness in humans: a positron emission tomographic study. J Neurosci 1999; 19:5506-5513.
41. Alkire MT, Haier RJ, Fallon JH. Toward a unified theory of narcosis: brain imaging evidence for a thalamocortical switch as the neurophysiologic basis of anesthetic-induced unconsciousness. Conscious Cogn 2000; 9:370-386.
42. Alkire MT, McReynolds JR, Hahn EL, Trivedi AN. Thalamic microinjection of nicotine reverses sevoflurane-induced loss of righting reflex in the rat. Anesthesiology 2007; 107:264-272.
43. Neumann MA, Eger EI, Weiskopf RB. Solubility of volatile anesthetics in bovine white matter, cortical gray matter, thalamus, hippocampus, and hypothalamic area. Anesth Analg 2005; 100:1003-1006.
44. Schneider G, Kochs EF. The search for structures and mechanisms controlling anesthesia-induced unconsciousness. Anesthesiology 2007; 107:195-198.
45. Overton E. About the general osmotic properties of the cell, their presumable causes, and their importance for physiology. Vierteljahresschr Naturforsch Ges Zü rich 1899; 44:88-135.
46. Overton E. Studies of narcosis. A contribution to general pharmacology. Jena, Germany: Gustav Fischer; 1901.
47. Meyer HH. Which property of anaesthetics causes their narcotic effect? Arch Exp Pathol Pharmakol (Naunyn-Schmiedebergs) 1899; 42:109- 118.
48. Campagna JA, Miller JW, Forman SA. Mechanisms of actions of inhaled anesthetics. N Engl J Med 2003; 348:2110-2124.
49. Mori T, Matubayasi N, Ueda I. Membrane expansion and inhalation anesthetics. Mean excess volume hypothesis. Mol Pharmacol 1984; 25:123-130.
50. Ueda I, Hirakawa M, Arakawa K, Kamaya H. Do anesthetics fluidize membranes? Anesthesiology 1986; 64:67-71.
51. Cantor RS. The lateral pressure profile in membranes: a physical mechanism of general anesthesia. Biochemistry 1997; 36:2339-2344.
52. Janoff AS, Miller KW. A critical assessment of the lipid theories of general anesthetic action. In: Chapman D, editor. Biological membranes. London, UK: Academic Press; 1982.
53. Halsey MJ, Wardley-Smith B. Pressure reversal of narcosis produced by anaesthetics, narcotics and tranquillisers. Nature 1975; 257:811-813.
54. Bailey CP, Green CJ, Halsey MJ, Wardley-Smith B. High pressure and intravenous steroid anesthesia in rats. J Appl Physiol 1977; 43: 183-188.
55. Trudell JR. A unitary theory of anesthesia based on lateral phase separations in nerve membranes. Biophys J 1977; 18:358-359.
56. Rosenberg PH, Jansson SE, Gripenberg J. Effects of halothane, thiopental, and lidocaine on fluidity of synaptic plasma membranes and artificial phospholipid membranes. Anesthesiology 1977; 46:322-326.
57. Ueda I, Shieh DD, Eyring H. Anesthetic interaction with a model cell membrane: expansion, phase transition, and melting of the lecithin monolayer. Anesthesiology 1974; 41:217-225.
58. Trudell JR, Hubbell WL, Cohen EN. The effect of two inhalation anesthetics on the order of spin-labeled phospholipid vesicles. Biochim Biophys Acta 1973; 291:321-327.
59. Miller KW, Pang KY. General anaesthetics can selectively perturb lipid bilayer membranes. Nature 1976; 263:253-255.
60. Eger EI, Saidman LJ, Brandstater B. Temperature dependence of halothane and cyclopropane anesthesia in dogs: correlation with some theories of anesthetic action. Anesthesiology 1965; 26:764-770.
61. Franks NP, Lieb WR. Do general anaesthetics act by competitive binding to specific receptors? Nature 1984; 310:599-601.
62. Koblin DD, Chortkoff BS, Laster MJ, et al. Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis. Anesth Analg 1994; 79:1043-1048.
63. Fang Z, Sonner J, Laster MJ, et al. Anesthetic and convulsant properties of aromatic compounds and cycloalkanes: implications for mechanisms of narcosis. Anesth Analg 1996; 83:1097-1104.
64. Kandel L, Chortkoff BS, Sonner J, et al. Nonanesthetics can suppress learning. Anesth Analg 1996; 82:321-326.
65. Sonner JM, Li J, Eger EI. Desflurane and the nonimmobilizer 1,2- dichlorohexafluorocyclobutane suppress learning by a mechanism independent of the level of unconditioned stimulation. Anesth Analg 1998; 87:200-205.
66. Raines DE, Miller KW. On the importance of volatile agents devoid of anesthetic action. Anesth Analg 1994; 79:1031-1033.
67. Lysko GS, Robinson JL, Casto R, Ferrone RA. The stereospecific effects of isoflurane isomers in vivo. Eur J Pharmacol 1994; 263:25-29.
68. Dickinson R, White I, Lieb WR, Franks NP. Stereoselective loss of righting reflex in rats by isoflurane. Anesthesiology 2000; 93:837-843.
69. Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994; 367:607-614.
70. Eckenhoff RG, Johansson JS. On the relevance of 'clinically relevant concentrations' of inhaled anesthetics in in vitro experiments. Anesthesiology 1999; 91:856-860.
71. Harrison NL. Ion channels take center stage: twin spotlights on two anesthetic targets. Anesthesiology 2000; 92:936-938.
72. Hemmings HC, Adamo AI. Effects of halothane and propofol on purified brain protein kinase C activation. Anesthesiology 1994; 81:147-155.
73. Gomez RS, Guatimosim C, Gomez MV. Mechanism of action of volatile anesthetics: role of protein kinase C. Cell Mol Neurobiol 2003; 23:877- 885.
74. Eckenhoff RG. Promiscuous ligands and attractive cavities: how do the inhaled anesthetics work? Mol Interv 2001; 1:258-268.
75. Mantz J, Cordier J, Giaume C. Effects of general anesthetics on intercellular communications mediated by gap junctions between astrocytes in primary culture. Anesthesiology 1993; 78:892-901.
76. Pennisi E. Genetics. Working the (gene count) numbers: finally, a firm answer? Science 2007; 316:1113.
77. Hemmings HC, Akabas MH, Goldstein PA, et al. Emerging molecular mechanisms of general anesthetic action. Trends Pharmacol Sci 2005; 26:503-510.
78. Sleigh J. Mechanisms of General Anesthesia. 81st Meeting of the International Anesthesia Research Society. Orlando, Florida, USA: IARS, Cleveland, USA; 2007.
79. Brunori M, Vallone B, Cutruzzola F, et al. The role of cavities in protein dynamics: crystal structure of a photolytic intermediate of a mutant myoglobin. Proc Natl Acad Sci U S A 2000; 97:2058-2063.
80. Eckenhoff RG, Johansson JS. Molecular interactions between inhaled anesthetics and proteins. Pharmacol Rev 1997; 49:343-367.
81. Eckenhoff MF, Eckenhoff RG. Quantitative autoradiography of halothane binding in rat brain. J Pharmacol Exp Ther 1998; 285:371-376.
82. Perouansky M, Hemmings HC, Pearce RA. Anesthetic effects on glutamatergic neurotransmission: lessons learned from a large synapse. Anesthesiology 2004; 100:470-472.
83. + channel, TREK-1. Br J Pharmacol 2007; 152:939-945.
84. Cheng G, Kendig JJ. Enflurane directly depresses glutamate AMPA and NMDA currents in mouse spinal cord motor neurons independent of actions on GABAA or glycine receptors. Anesthesiology 2000; 93:1075-1084.
85. Cheng G, Kendig JJ. Pre and postsynaptic volatile anaesthetic actions on glycinergic transmission to spinal cord motor neurons. Br J Pharmacol 2002; 136:673-684.
86. Wang MY, Rampil IJ, Kendig JJ. Ethanol directly depresses AMPA and NMDA glutamate currents in spinal cord motor neurons independent of actions on GABAA or glycine receptors. J Pharmacol Exp Ther 1999; 290:362-367.
87. Antognini JF, Wang XW, Carstens E. Quantitative and qualitative effects of isoflurane on movement occurring after noxious stimulation. Anesthesiology 1999; 91:1064-1071.
88. Sonner JM, Antognini JF, Dutton RC, et al. Inhaled anesthetics and immobility: mechanisms, mysteries, and minimum alveolar anesthetic concentration. Anesth Analg 2003; 97:718-740.
89. Mihic SJ, Ye Q, Wick MJ, et al. Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 1997; 389:385-389.
90. Perouansky M, Pearce RA. Is anesthesia caused by potentiation of synaptic or intrinsic inhibition? Recent insights into the mechanisms of volatile anesthetics. J Basic Clin Physiol Pharmacol 2000; 11:83-107.
91. Li X, Czajkowski C, Pearce RA. Rapid and direct modulation of GABAA receptors by halothane. Anesthesiology 2000; 92:1366-1375.
92. + channels. Nat Neurosci 1999; 2:422-426.
93. + channels: an important target for volatile anesthetics? Nat Neurosci 1999; 2:395-396.
94. Kindler C. Effects of different classes of anesthetics on a new family of potassium channels with two pore domains in tandem [dissertation]. Basel, Switzerland: University of Basel; 2001. pp. 74-95.
95. Tonner PH, Miller KW. Molecular sites of general anaesthetic action on acetylcholine receptors. Eur J Anaesth 1995; 12:21-30.
96. Flood P, Ramirez-Latorre J, Role L. Alpha 4 beta 2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but alpha 7-type nicotinic acetylcholine receptors are unaffected. Anesthesiology 1997; 86:859-865.
97. Dildy-Mayfield JE, Eger EI, Harris RA. Anesthetics produce subunitselective actions on glutamate receptors. J Pharmacol Exp Ther 1996; 276:1058-1065.
98. Franks NP, Dickinson R, de Sousa SL, et al. How does xenon produce anaesthesia? Nature 1998; 396:324.
99. Harrison NL, Kugler JL, Jones MV, et al. Positive modulation of human gamma-aminobutyric acid type A and glycine receptors by the inhalation anesthetic isoflurane. Mol Pharmacol 1993; 44:628-632.
100. Krasowski MD, Harrison NL. General anaesthetic actions on ligand-gated ion channels. Cell Mol Life Sci 1999; 55:1278-1303.
101. Jevtovic-Todorovic V, Todorovic SM, Mennerick S, et al. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med 1998; 4:460-463.
102. Raines DE, Claycomb RJ, Scheller M, Forman SA. Nonhalogenated alkane anesthetics fail to potentiate agonist actions on two ligand-gated ion channels. Anesthesiology 2001; 95:470-477.
103. Zeilhofer HU, Swandulla D, Geisslinger G, Brune K. Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. Eur J Pharmacol 1992; 213:155-158.
104. Flood P, Krasowski MD. Intravenous anesthetics differentially modulate ligand-gated ion channels. Anesthesiology 2000; 92:1418-1425.
105. Orser BA. Lifting the fog around anesthesia. Sci Am 2007; 296:54-61.
106. Krasowski MD, Jenkins A, Flood P, et al. General anesthetic potencies of a series of propofol analogs correlate with potency for potentiation of gamma-aminobutyric acid (GABA) current at the GABA(A) receptor but not with lipid solubility. J Pharmacol Exp Ther 2001; 297: 338-351.
107. Tomlin SL, Jenkins A, Lieb WR, Franks NP. Stereoselective effects of etomidate optical isomers on gamma-aminobutyric acid type A receptors and animals. Anesthesiology 1998; 88:708-717.
108. Hales TG, Lambert JJ. The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones. Br J Pharmacol 1991; 104:619-628.
109. Rudolph U, Crestani F, Benke D, et al. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 1999; 401:796-800.
110. Drafts BC, Fisher JL. Identification of structures within GABAA receptor alpha subunits that regulate the agonist action of pentobarbital. J Pharmacol Exp Ther 2006; 318:1094-1101.
111. Borghese CM, Werner DF, Topf N, et al. An isoflurane- and alcoholinsensitive mutant GABA(A) receptor alpha(1) subunit with near-normal apparent affinity for GABA: characterization in heterologous systems and production of knockin mice. J Pharmacol Exp Ther 2006; 319: 208-218.
112. Belelli D, Lambert JJ, Peters JA, et al. The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid. Proc Natl Acad Sci U S A 1997; 94:11031-11036.
113. Nishikawa K, Jenkins A, Paraskevakis I, Harrison NL. Volatile anesthetic actions on the GABAA receptors: contrasting effects of alpha 1(S270) and beta 2(N265) point mutations. Neuropharmacology 2002; 42:337- 345.
114. Jinks SL, Atherley RJ, Dominguez CL, et al. Isoflurane disrupts central pattern generator activity and coordination in the lamprey isolated spinal cord. Anesthesiology 2005; 103:567-575.
115. Franks NP, Lieb WR. Stereospecific effects of inhalational general anesthetic optical isomers on nerve ion channels. Science 1991; 254:427-430.
116. Hille B. Ionic channels of excitable membranes. Sunderland, USA: Sinauer Associates, Inc.; 2001.
117. + channel. Anesthesiology 1998; 88:1076-1084.
118. + channel KCNK5. Anesthesiology 2000; 92:1722-1730.
119. Winegar BD, Owen DF, Yost CS, et al. Volatile general anesthetics produce hyperpolarization of Aplysia neurons by activation of a discrete population of baseline potassium channels. Anesthesiology 1996; 85:889-900.
120. + channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 2004; 65:443-452.
121. Mathie A, Veale EL. Therapeutic potential of neuronal two-pore domain potassium-channel modulators. Curr Opin Investig Drugs 2007; 8:555- 562.
122. Liu C, Au JD, Zou HL, et al. Potent activation of the human tandem pore domain K channel TRESK with clinical concentrations of volatile anesthetics. Anesth Analg 2004; 99:1715-1722.
123. + channel involved in neuroprotection and general anesthesia. EMBO J 2004; 23:2684-2695.
124. Papazian DM, Schwarz TL, Tempel BL, et al. Cloning of genomic and complementary DNA from Shaker, a putative potassium channel gene from Drosophila. Science 1987; 237:749-753.
125. Haydon DA, Urban BW. The actions of some general anaesthetics on the potassium current of the squid giant axon. J Physiol 1986; 373:311-327.
126. Friederich P, Urban BW. Interaction of intravenous anesthetics with human neuronal potassium currents in relation to clinical concentrations. Anesthesiology 1999; 91:1853-1860.
127. Zucker JR. ATP-sensitive potassium channel agonists do not alter MAC for isoflurane in rats. Anesthesiology 1992; 76:560-563.
128. Hara K, Harris RA. The anesthetic mechanism of urethane: the effects on neurotransmitter-gated ion channels. Anesth Analg 2002; 94:313-318.
129. Lin LH, Chen LL, Harris RA. Enflurane inhibits NMDA, AMPA, and kainateinduced currents in Xenopus oocytes expressing mouse and human brain mRNA. FASEB J 1993; 7:479-485.
130. McFarlane C, Warner DS, Todd MM, Nordholm L. AMPA receptor competitive antagonism reduces halothane MAC in rats. Anesthesiology 1992; 77:1165-1170.
131. Minami K, Wick MJ, Stern-Bach Y, et al. Sites of volatile anesthetic action on kainate (Glutamate receptor 6) receptors. J Biol Chem 1998; 273:8248-8255.
132. Hollmann MW, Liu HT, Hoenemann CW, et al. Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics. Anesth Analg 2001; 92:1182-1191.
133. Maclver MB, Mikulec AA, Amagasu SM, Monroe FA. Volatile anesthetics depress glutamate transmission via presynaptic actions. Anesthesiology 1996; 85:823-834.
134. Joo DT, Gong D, Sonner JM, et al. Blockade of AMPA receptors and volatile anesthetics: reduced anesthetic requirements in GluR2 null mutant mice for loss of the righting reflex and antinociception but not minimum alveolar concentration. Anesthesiology 2001; 94: 478-488.
135. Sonner JM, Vissel B, Royle G, et al. The effect of three inhaled anesthetics in mice harboring mutations in the GluR6 (kainate) receptor gene. Anesth Analg 2005; 101:143-148.
136. Sato Y, Kobayashi E, Murayama T, et al. Effect of N-methyl-D-aspartate receptor epsilon1 subunit gene disruption of the action of general anesthetic drugs in mice. Anesthesiology 2005; 102:557-561.
137. Dickinson R, Peterson BK, Banks P, et al. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology. Anesthesiology 2007; 107:756-767.
138. Role LW, Berg DK. Nicotinic receptors in the development and modulation of CNS synapses. Neuron 1996; 16:1077-1085.
139. Flood P, Sonner JM, Gong D, Coates KM. Heteromeric nicotinic inhibition by isoflurane does not mediate MAC or loss of righting reflex. Anesthesiology 2002; 97:902-905.
140. Eger EI, Zhang Y, Laster M, et al. Acetylcholine receptors do not mediate the immobilization produced by inhaled anesthetics. Anesth Analg 2002; 94:1500-1504.
141. Flood P, Role LW. Neuronal nicotinic acetylcholine receptor modulation by general anesthetics. Toxicol Lett 1998; 100-101:149-153.
142. Flood P, Sonner JM, Gong D, Coates KM. Isoflurane hyperalgesia is modulated by nicotinic inhibition. Anesthesiology 2002; 97: 192-198.
143. Seitz PA, ter Riet M, Rush W, Merrell WJ. Adenosine decreases the minimum alveolar concentration of halothane in dogs. Anesthesiology 1990; 73:990-994.
144. Ma HC, Wang YF, Feng CS, et al. Effects of adenosine agonist Rphenylisopropyl- adenosine on halothane anesthesia and antinociception in rats. Acta Pharmacol Sin 2005; 26:181-185.
145. Maricq AV, Peterson AS, Brake AJ, et al. Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 1991; 254:432-437.
146. Minami K, Minami M, Harris RA. Inhibition of 5-hydroxytryptamine type 2A receptor-induced currents by n-alcohols and anesthetics. J Pharmacol Exp Ther 1997; 281:1136-1143.
147. Rampil IJ, Laster MJ, Eger EI. Antagonism of the 5-HT(3) receptor does not alter isoflurane MAC in rats. Anesthesiology 2001; 95:562-564.
148. Fukuda S, Warner DS. Cerebral protection. Br J Anaesth 2007; 99:10- 17.
149. Sakai H, Sheng H, Yates RB, et al. Isoflurane provides long-term protection against focal cerebral ischemia in the rat. Anesthesiology 2007; 106:92-99.
150. Bickler PE, Warner DS, Stratmann G, Schuyler JA. gamma-Aminobutyric acid-A receptors contribute to isoflurane neuroprotection in organotypic hippocampal cultures. Anesth Analg 2003; 97:564-571.
151. 2+ influx. Anesthesiology 2006; 104:995-1003.
152. Dahmani S, Rouelle D, Gressens P, Mantz J. Effects of dexmedetomidine on hippocampal focal adhesion kinase tyrosine phosphorylation in physiologic and ischemic conditions. Anesthesiology 2005; 103:969- 977.
153. Liu C, Cotten JF, Schuyler JA, et al. Protective effects of TASK-3 (KCNK9) and related 2P K channels during cellular stress. Brain Res 2005; 1031:164-173.
154. Moller JT, Cluitmans P, Rasmussen LS, et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. Lancet 1998; 351:857-861.
155. Fong HK, Sands LP, Leung JM. The role of postoperative analgesia in delirium and cognitive decline in elderly patients: a systematic review. Anesth Analg 2006; 102:1255-1266.
156. Crosby C, Culley DJ, Baxter MG, et al. Spatial memory performance 2 weeks after general anesthesia in adult rats. Anesth Analg 2005; 101:1389-1392.
157. Culley DJ, Raghavan SV, Waly M, et al. Nitrous oxide decreases cortical methionine synthase transiently but produces lasting memory impairment in aged rats. Anesth Analg 2007; 105:83-88.
158. Rasmussen LS, Johnson T, Kuipers HM, et al. Does anaesthesia cause postoperative cognitive dysfunction? A randomised study of regional versus general anaesthesia in 438 elderly patients. Acta Anaesthesiol Scand 2003; 47:260-266.
159. Jevtovic-Todorovic V, Hartman RE, Izumi Y, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003; 23:876-882.
160. Wilder RT, Flick RP, Sprung J, et al. Relationship between exposure to anesthesia and subsequent learning disabilities in children [ASA abstract]. Anesthesiology 2008; 109:A1416.
161. Rajaram S, Spangler TL, Sedensky MM, Morgan PG. A stomatin and a degenerin interact to control anesthetic sensitivity in Caenorhabditis elegans. Genetics 1999; 153:1673-1682.
162. Campbell DB, Nash HA. Use of Drosophila mutants to distinguish among volatile general anesthetics. Proc Natl Acad Sci U S A 1994; 91:2135- 2139.
163. Koubi L, Tarek M, Klein ML, Scharf D. Distribution of halothane in a dipalmitoylphosphatidylcholine bilayer from molecular dynamics calculations. Biophys J 2000; 78:800-811.
164. Kitamura A, Sato R, Marszalec W, et al. Halothane and propofol modulation of gamma-aminobutyric acid A receptor single-channel currents. Anesth Analg 2004; 99:409-415.
165. Gottschalk A, Haney P. Computational aspects of anesthetic action in simple neural models. Anesthesiology 2003; 98:548-564.